CLINICAL_TRIALS
trial_result
· 2022-01-14
Clinical Trial Update: Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder [Phase 2]
Summary
Phase 2 pharmacogenetic study investigating ondansetron for alcohol use disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2022-01-14